DD
DuPont de Nemours, Inc.
Related News
SEC Filings
Earnings Trend
Screening
Compare
Economic Calendar
We use cookies in accordance with European GDPR standards to improve site usability, analytics, and deliver personalized advertising.Learn moreCookie Settings
DuPont remains undervalued, but I move from Strong Buy to Buy due to Q3 guidance concerns and currency headwinds. Q2 is expected to deliver a small beat, driven by strong healthcare and aerospace, tho
